VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

SOHO 2022 | Orthopedic adverse events among AYA patients with ALL treated with asparaginase

In this video, Marlise Luskin, MD, MSCE, Dana-Farber Cancer Institute, Boston, MA, discusses toxicities observed in adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) treated with asparaginase, drawing focus on orthopedic adverse events, and further highlights the importance of investigating these. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter